COMPANY
Molsoft
Molsoft provides molecular modeling and drug design software (the ICM product line), databases and consulting for structural proteomics, bioinformatics and cheminformatics. From company website Source · Oct 12, 2026
NIH awards 13
- NIH award 5R43GM090418-02 FY2011: $199,542 awarded for that fiscal year; activity R43 (SBIR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, SAN DIEGO, CA. Glycoprotein Modeling System for Internal Coordinate source ↗
- NIH award 5R43MH084374-02 FY2010: $247,470 awarded for that fiscal year; activity R43 (SBIR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, SAN DIEGO, CA. Computer-assisted identification and design of subtyp source ↗
- NIH award 1R43GM090418-01 FY2010: $199,705 awarded for that fiscal year; activity R43 (SBIR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, SAN DIEGO, CA. Glycoprotein Modeling System for Internal Coordinate source ↗
- NIH award 1R43MH084374-01A1 FY2009: $250,000 awarded for that fiscal year; activity R43 (SBIR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, SAN DIEGO, CA. Computer-assisted identification and design of subt source ↗
- NIH award 1R41GM087017-01 FY2009: $100,000 awarded for that fiscal year; activity R41 (STTR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, SAN DIEGO, CA. Next Generation Forcefield for Internal Coordinate Me source ↗
- NIH award 1R43GM074343-01A1 FY2006: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, San Diego, CA. Integrated Protein Surface Annotation Suite source ↗
- NIH award 5R43AI056784-02 FY2004: $499,432 awarded for that fiscal year; activity R43 (SBIR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, San Diego, CA. Rational Design of Inhibitors of Yersinia pestis EF-T source ↗
- NIH award 5R42DK059041-03 FY2004: $242,424 awarded for that fiscal year; activity R42 (STTR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, San Diego, CA. Rational Development of Thyroid Receptor Antagonists source ↗
- NIH award 1R41CA101295-01A1 FY2004: $100,000 awarded for that fiscal year; activity R41 (STTR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, San Diego, CA. Rational Development of TCF/Beta-Catenin Antagonist source ↗
- NIH award 1R43AI056784-01 FY2003: $499,432 awarded for that fiscal year; activity R43 (SBIR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, LA JOLLA, CA. Rational Design of Inhibitors of Yersinia pestis EF-Tu source ↗
- NIH award 2R42DK059041-02 FY2003: $242,365 awarded for that fiscal year; activity R42 (STTR); PI TOTROV, MAXIM; recipient as written: MOLSOFT, LLC, LA JOLLA, CA. Rational Development of Thyroid Receptor Antagonists source ↗
- NIH award 1R43HG002471-01 FY2002: $99,934 awarded for that fiscal year; activity R43 (SBIR); PI SCHAPIRA, MATTHIEU; recipient as written: MOLSOFT, LLC, LA JOLLA, CA. Sequence/Structure Annotation of Protein Families source ↗
- NIH award 1R41DK059041-01 FY2000: $100,000 awarded for that fiscal year; activity R41 (STTR); PI SCHAPIRA, MATTHIEU; recipient as written: MOLSOFT, LLC, LA JOLLA, CA. RATIONAL DEVELOPMENT OF THYROID RECEPTOR ANTAGONI source ↗